Australia - English - Department of Health (Therapeutic Goods Administration)

link orthopaedics australia pty ltd - 34076 - polyethylene acetabulum prosthesis - the ip x-linked polyethylene acetabular cup implant for cementable fixation in the acetabulum used in primary hip arthroplasty. polyethylene acetabular cups are supplied with x-ray markers, made from cocrmo, for easy location on the x-ray and are suitable for use with ceramic or cocrmo heads with integrated spacers on external profile to give homogeneous cement mantle x-linked polyethylene acetabular cup indicated for cementable fixation in the acetabulum in the treatment of mobility-limiting diseases, fractures or defects which cannot be treated by conservative or osteosynthetic procedures ? primary and secondary coxarthrosis ? osteoarthritis ? necrosis of the femoral head ? femoral neck fractures ? revision after implant loosening

Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - clinical chemistry - the atellica ch inorganic phosphorus (ip) assay is for in vitro diagnostic use in the quantitative determination of inorganic phosphorous in human serum, plasma (lithium heparin), and urine using the atellica ch analyzer and the atellica ci analyzer. such measurements are used in the diagnosis and treatment of kidney diseases, parathyroid gland disorders, and vitamin d imbalance.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - furosemide, quantity: 20 mg - tablet - excipient ingredients: magnesium stearate; sodium starch glycollate type a; pregelatinised maize starch; maize starch; lactose monohydrate - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - furosemide, quantity: 40 mg - tablet - excipient ingredients: sodium starch glycollate type a; maize starch; lactose monohydrate; magnesium stearate; pregelatinised maize starch - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

Austria - English - HMA (Heads of Medicines Agencies)

merial - ibv strain mass41 10 hi, ndv strain ulster 2c 10 hi, turkey rhinotracheitis virus 60 ip - emulsion for injection - chicken layers - avian infectious bronchitis virus vaccine + newcastle disease virus / paramyxovirus vaccine + avian rhinotracheitis virus vaccin

Germany - English - HMA (Heads of Medicines Agencies)

merial - ibv strain mass41 10 hi, ndv strain ulster 2c 10 hi, turkey rhinotracheitis virus 60 ip - emulsion for injection - chicken layers - avian infectious bronchitis virus vaccine + newcastle disease virus / paramyxovirus vaccine + avian rhinotracheitis virus vaccin

Greece - English - HMA (Heads of Medicines Agencies)

merial - ibv strain mass41 10 hi, ndv strain ulster 2c 10 hi, turkey rhinotracheitis virus 60 ip - emulsion for injection - chicken layers - avian infectious bronchitis virus vaccine + newcastle disease virus / paramyxovirus vaccine + avian rhinotracheitis virus vaccin

Spain - English - HMA (Heads of Medicines Agencies)

merial - ibv strain mass41 10 hi, ndv strain ulster 2c 10 hi, turkey rhinotracheitis virus 60 ip - emulsion for injection - chicken layers - avian infectious bronchitis virus vaccine + newcastle disease virus / paramyxovirus vaccine + avian rhinotracheitis virus vaccin

France - English - HMA (Heads of Medicines Agencies)

merial - ibv strain mass41 10 hi, ndv strain ulster 2c 10 hi, turkey rhinotracheitis virus 60 ip - emulsion for injection - chicken layers - avian infectious bronchitis virus vaccine + newcastle disease virus / paramyxovirus vaccine + avian rhinotracheitis virus vaccin

Hungary - English - HMA (Heads of Medicines Agencies)

merial - ibv strain mass41 10 hi, ndv strain ulster 2c 10 hi, turkey rhinotracheitis virus 60 ip - emulsion for injection - chicken layers - avian infectious bronchitis virus vaccine + newcastle disease virus / paramyxovirus vaccine + avian rhinotracheitis virus vaccin